Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR in Bipolar Depression with Comorbid GAD
NCT00671853Phase 3Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Apr 2008
- Primary completion
- Mar 2011
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in bipolar disorder (BD), generalized anxiety disorder (GAD), sponsored by University Hospitals Cleveland Medical Center. Started Apr 2008; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00671853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671853.